版本:
中国

BRIEF-Audentes Therapeutics says entered into an amendment to exclusive license and collaboration agreement, dated May 3, 2016

April 3 Audentes Therapeutics Inc

* Audentes Therapeutics Inc - on March 21, 2017, co entered into an amendment to exclusive license and collaboration agreement, dated May 3, 2016

* Audentes Therapeutics Inc - parties now intent to extend work plan to include additional studies - SEC filing Source text: (bit.ly/2nCpWlZ) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐